Stomach Cancer Trial, Recruiting NCT03978078 Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT03978078
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older
  • People who have been diagnosed (confirmed by tissue testing) with adenocarcinoma — a specific type of cancer — in one of these locations: colon, rectum, small intestine, pancreas, stomach, bile duct, or oesophagus
  • People who are about to start their first or second round of chemotherapy and/or targeted therapy for cancer that has spread (metastatic)
  • People who have signed an informed consent form agreeing to take part

Who may not be able to join:

  • People under 18 years old
  • People whose cancer is not the adenocarcinoma type
  • People who have already started chemotherapy and/or targeted therapy as their first or second treatment for metastatic disease
  • Women who are pregnant or breastfeeding
  • People who are not registered with a social security system (confirm with trial site)
  • People for whom regular follow-up appointments would not be possible, due to psychological, family, social, or geographical reasons
  • People who are already taking part in a Phase I or Phase II clinical trial that changes their usual care and requires additional specific blood samples

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Thibault Mazard, MD, Institut régional du cancer de Montpellier

Phone: 4 67 61 31 02

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Registry
ClinicalTrials.gov
Start date
12 September 2016
Est. completion
1 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Number of clinical risk factors for metastatic digestive cancer; Number of biological risk factors for metastatic digestive cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov